Clinical aspects: from systemic inflammation to 'immunoparalysis'.
about
Immune modulation in the treatment of respiratory infectionImmunodepression in the surgical patient and increased susceptibility to infection.From bench to bedside: bacterial growth and cytokines.A Review of GM-CSF Therapy in SepsisPPARγ in Bacterial Infections: A Friend or Foe?Three Hypothetical Inflammation Pathobiology Phenotypes and Pediatric Sepsis-Induced Multiple Organ Failure Outcome.IRAK-M regulates chromatin remodeling in lung macrophages during experimental sepsis.Invasive pulmonary aspergillosis in a patient presenting with idiopathic systemic capillary leak syndrome.Soluble ST2 plasma concentrations predict mortality in severe sepsis.Mitochondrial function of immune cells in septic shock: A prospective observational cohort study.Calcineurin inactivation leads to decreased responsiveness to LPS in macrophages and dendritic cells and protects against LPS-induced toxicity in vivoDivergence of protection induced by bacterial products and sepsis-induced immune suppression.Soluble ST2 in the fetal inflammatory response syndrome: in vivo evidence of activation of the anti-inflammatory limb of the immune responseNew approaches to sepsis: molecular diagnostics and biomarkers.Intensive care unit-acquired weakness (ICUAW) and muscle wasting in critically ill patients with severe sepsis and septic shockModulation of TNF-α mRNA stability by human antigen R and miR181s in sepsis-induced immunoparalysis.Depressed Monocytic Activity may be a Predictor for Sepsis.Endotoxemia related to cardiopulmonary bypass is associated with increased risk of infection after cardiac surgery: a prospective observational study.Clinical implications and molecular mechanisms of immunoparalysis after cardiopulmonary bypass.MicroRNA-19a and CD22 Comprise a Feedback Loop for B Cell Response in Sepsis.Fish oil in critical illness: mechanisms and clinical applications.Cytokine serum levels during post-transplant adverse events in 61 pediatric patients after hematopoietic stem cell transplantation.Pathophysiology of sepsis-related cardiac dysfunction: driven by inflammation, energy mismanagement, or both?Mechanical Ventilation Induces an Inflammatory Response in Preinjured Lungs in Late Phase of Sepsis.Insights into deregulated TNF and IL-10 production in malaria: implications for understanding severe malarial anaemia.Pivotal role of signal transducer and activator of transcription (Stat)4 and Stat6 in the innate immune response during sepsis.Cytokines in sepsis: potent immunoregulators and potential therapeutic targets--an updated view.Downregulation of CD40 ligand response in monocytes from sepsis patients.Methyl-2-acetamidoacrylate, an ethyl pyruvate analog, decreases sepsis-induced acute kidney injury in mice.Targeting RAGE in sepsis.Early down-regulation of the pro-inflammatory potential of monocytes is correlated to organ dysfunction in patients after severe multiple injury: a cohort study.Phenotype changes and impaired function of dendritic cell subsets in patients with sepsis: a prospective observational analysisThe new normal: immunomodulatory agents against sepsis immune suppression.Sepsis induced immunosuppression: Implications for secondary infections and complications.Novel GM-CSF-based vaccines: One small step in GM-CSF gene optimization, one giant leap for human vaccines.Immunological priming requires regulatory T cells and IL-10-producing macrophages to accelerate resolution from severe lung inflammation.Expression of type I interferon by splenic macrophages suppresses adaptive immunity during sepsis.Expansion of CD14(+)CD16(+) monocytes is related to acute leukemia.Immunoparalysis and nosocomial infection in children with multiple organ dysfunction syndromeInterleukin-1 receptor-associated kinase M-deficient mice demonstrate an improved host defense during Gram-negative pneumonia.
P2860
Q24791001-FF5CDB73-F33A-4F0F-8AF1-39BA4C625447Q24796749-FC4BF685-B5E6-477A-95D9-053D9DCE6289Q24797951-A96A1E41-2B4B-4066-AEFC-621E6C247F14Q26774775-CEFC1D17-FBDB-45D2-8C18-714E5B98E6EDQ28070173-9D66EE20-84C5-443E-B352-E14CF0A61625Q33441000-0A1DFF59-6D5C-4D92-A246-3EAE69FC29FAQ33618905-5318BF3F-7C12-419D-85A4-229C0AE4DDEEQ33691672-AD7CFDEB-21F8-4776-A166-470AF71AD4E5Q33722112-8CBC9F12-6268-4784-969A-D7F14BDBA674Q33773086-E8E3BBB7-F7D7-46C2-9422-26B8CCECC287Q33903361-EC6A09A5-6032-43D4-9FE3-A47E6ACE581FQ33946614-49450160-DE9B-4B3D-93F7-D82D806BB01BQ34281893-1F63ACC7-0A46-46A7-8458-E68CAD0F2435Q34303687-CF6450EB-1A27-4B73-BC51-113B3BC7C503Q34697264-520434DF-F0FA-440E-AAFF-101CEA9D9EAAQ35084392-3EDBBA82-3DA5-49EB-B299-3567801F615BQ35544877-86FCADFA-77C9-4CE0-B210-F86DCA7F99FAQ35567043-8821A97A-9D77-4630-BD5D-9749B3AE600FQ35683171-4397C126-9EF2-4CF6-9ED2-5FCF0138BA09Q35694299-0F8FEFE3-74E0-4D38-A0E3-A444AA394952Q35730995-643F3792-179B-4110-9003-2E7694A036C3Q35757981-9006AB47-06C1-498D-97E8-5DBF7352627EQ35761448-EE2B8BC0-0460-467F-A9C7-662144F1AFCEQ35805729-81978AF5-138C-44D7-8AB9-0283273EF3FFQ36311915-BC049912-A333-435C-9E85-B0B06EE64D2BQ36369264-EB45F5C2-FAA0-4DA0-8422-59EC4A62B69BQ36990515-E9C24E9C-E354-4200-A4BA-9CFCDDB60CEEQ36994261-12F72662-F3C2-4FFB-9B11-3AA7484563A2Q37018467-E638FC69-8994-4B1F-83D0-FF522AE8BF1BQ37078482-1DCDC01B-6534-4F6E-A8D9-8BFCD6A0F810Q37279867-724EADD9-7375-4983-A7F3-91FF8C202349Q37360321-A914A54E-B36C-4AAD-8F59-8AF150214133Q37686624-D5E9A19B-2A2D-4187-9435-6AAF9F5EC67BQ38148132-A78176B9-94A6-45E6-96BB-32C41EFB7F55Q38936958-B644F60F-50A6-401F-82DA-F0248C004A5AQ39001670-D7AB435E-A594-47B5-9D42-0E0F96B4809BQ40204301-956245B3-C60B-4439-81D1-58AA2E06C3FFQ40342447-56086842-EA21-4D16-AED3-5FD1C7475905Q41155671-A287EB21-F164-4E46-8CAD-F212DA763CF7Q41826464-E687F811-174B-419D-9A10-C7DDE32BD52A
P2860
Clinical aspects: from systemic inflammation to 'immunoparalysis'.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Clinical aspects: from systemic inflammation to 'immunoparalysis'.
@ast
Clinical aspects: from systemic inflammation to 'immunoparalysis'.
@en
type
label
Clinical aspects: from systemic inflammation to 'immunoparalysis'.
@ast
Clinical aspects: from systemic inflammation to 'immunoparalysis'.
@en
prefLabel
Clinical aspects: from systemic inflammation to 'immunoparalysis'.
@ast
Clinical aspects: from systemic inflammation to 'immunoparalysis'.
@en
P2093
P1433
P1476
Clinical aspects: from systemic inflammation to 'immunoparalysis'.
@en
P2093
P304
P577
2000-01-01T00:00:00Z